Vimarsana
Biggest News Aggregation in the World

Lova Sun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lova Sun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lova Sun Today - Breaking & Trending Today

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, "Advancing the Cardiovascular Care of the Oncology Patient" - Vimarsana News

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, "Advancing the Cardiovascular Care of the Oncology Patient"

The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held at the Heart House in Washington, D.C., Feb. 9-11, 2024. The event is offered as an interdisciplinary and interspecialty course with a robust program providing clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in everyday practice.

Lung cancer: Should you stop immunotherapy after 2 years? - Vimarsana News

Lung cancer: Should you stop immunotherapy after 2 years?

Researchers are reporting that continuing to use immune checkpoint inhibitors drugs for people with late-stage non-small cell lung cancer doesn't appear to improve their chances of survival

Should NSCLC Patients Receive Immunotherapy 'Indefinitely'? - Vimarsana News

Should NSCLC Patients Receive Immunotherapy 'Indefinitely'?

Most long-term responders to immunotherapy continue taking the drugs after 2 years. But data show long-term use likely offers no survival benefit.

Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer - Vimarsana News

Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer

THURSDAY, June 29, 2023 (HealthDay News) -- The burden of suboptimally controlled cardiovascular (CV) risk factors and incident risk of stroke and myocardial infarction (MI) are considerable in patients with

Research shows 'substantial' cardiovascular risk among patients with head and neck cancer - Vimarsana News

Research shows 'substantial' cardiovascular risk among patients with head and neck cancer

Individuals with newly diagnosed head and neck squamous cell carcinoma are at high risk for adverse cardiovascular events, results of a retrospective study of U.S. veterans showed. Findings from the analysis, published in JAMA Otolaryngology – Head & Neck Surgery, indicate suboptimal control of multiple cardiovascular risk factors among these patients, leading to increased risk for

Source: healio.com